维普中文期刊产品整合服务
256篇 您的检索式:作者名="Tripepi"
    题名 作者 年代 出处 被引量
1Impact of age on feasibility and short-term outcomes of ERAS after laparoscopic colorectal resection显示文摘BACKGROUND There is still large debate on feasibility and advantages of fast-track protocols in elderly population after colorectal surgery.AIM To investigate the impact of age on feasibility and short-term results of enhanced recovery protocol(ERP)after laparoscopic colorectal resection.METHODS Data from 225 patients undergoing laparoscopic colorectal resection and ERP between March 2014 and July 2018 were retrospectively analyzed.Three groups were considered according to patients’age:Group A,65 years old or less,Group B,66 to 75 years old and Group C,76 years old or more.Clinic and pathological data were compared amongst groups together with post-operative outcomes including post-operative overall and surgery-specific complications,mortality and readmission rate.Differences in post-operative length of stay and adherence to ERP’s items were evaluated in the three study groups.RESULTS Among the 225 patients,112 belonged to Group A,57 to Group B and 56 to Group C.Thirty-day overall morbidity was 32.9%whilst mortality was nihil.Though the percentage of complications progressively increased with age(25.9%vs 36.8%vs 42.9%),no differences were observed in the rate of major complications(4.5%vs 3.5%vs 1.8%),prolonged post-operative ileus(6.2%vs 12.2%vs 10.7%)and anastomotic leak(2.7%vs 1.8%vs 1.8%).Significant differences in recovery outcomes between groups were observed such as delayed urinary catheter removal(P=0.032)and autonomous deambulation(P=0.013)in elderly patients.Although discharge criteria were achieved later in older patients(3 d vs 3 d vs 4 d,P=0.040),post-operative length of stay was similar in the 3 groups(5 d vs 6 d vs 6 d).CONCLUSION ERPs can be successfully and safely applied in elderly undergoing laparoscopic colorectal resection.Corrado Pedrazzani Cristian Conti Giulia Turri Enrico Lazzarini Marzia Tripepi Giovanni Scotton Matteo Rivelli Alfredo Guglielmi 2019World Journal of Gastrointestinal Surgery2019,11,10:4
2Low triiodothyronine:a new facet of inflammation in end-stage renal disease显示文摘 Tripepi G Cutrupi S 2005J Am Soc Nephrol2005,16,9:1
3Blood pressure variability in chronic kidney disease patients 显示文摘MALLAMACI F1 TRIPEPI G 2013Blood Purif2013,36,1:1
4Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease显示文摘Zoccali C Mallamaci F Tripepi G Benedetto FA Cutrupi S Parlongo S Malatino LS Bonanno G Seminara G Rapisarda F Fatuzzo P Buemi M Nicocia G Tanaka S Ouchi N Kihara S Funahashi T Matsuzawa Y 2002J Am Soc Nephrol2002,13,1:1
5Novel cardiovascular risk factors in end-stage renal disease显示文摘Zoccali C Mallamaci F Tripepi G 2004J Am Soc Nephrol2004,15,1:1
6血清碱性磷酸酶对未治疗的高血压患者的内皮依赖性血管舒张的不良影响显示文摘组织非特异性碱性磷酸酶是一般人群和肾或心血管病患者总死亡率及心血管死亡率的强有力预测因子。该研究纳入未经治疗的高血压患者500例,按照血清碱性磷酸酶三分位分组,分析血清碱性磷酸酶水平和血管内皮功能(通过应变仪体积描记法评估)可能存在的关联。结果:血管对乙酰胆碱的最大反应与碱性磷酸酶水平呈负相关(r=一0.55,P〈0.01),该相关性独立于人口和传统危险因素,如体质量指数,估算的肾小球滤过率,血清磷和钙,C反应蛋白和蛋白尿。刘莉 叶鹏 Perticone F Perticone M Maio R Sciacqua A Andreucci M Tripepi G Corrao S Mallamaci F Sesti G Zoccali C 2015中华高血压杂志2015,23,8:1
7Inflammation markers,adhesion molecules,and all-cause and cardiovascular mortality in patients with ESRD:searching for the best risk marker by multivariate modeling显示文摘 Mallamaci F Zoccali C 2005J Am Soc Nephrol2005,16,1:1
8Vitamin D levels and patient outcome in chronic kidney disease 显示文摘Ravani P Malberti F Tripepi G 2009Kidney Int2009,75,1:1
9Novel cardiovascular risk factors in end-stage renal disease显示文摘Zoccali C Mallamaci F Tripepi G 2004J Am Soc Nephrol2004,15,1:1
10Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease显示文摘Francesca Mallamaci Giovanni Tripepi Renke Maas 2004J Am Soc Nephrol2004,15,2:1
11Novel cardiovascularrisk factors in end-stage renal disease显示文摘Zoccali C Mallamaci F Tripepi G 2004J Am SocNephrol2004,15,:1
12Predictors of cardio- vascular death in ESRD显示文摘ZOCCALI C TRIPEPI G MALLAMACI F 2005Semin Nephrol2005,25,6:1
13Novel cardiovascular risk factors in end-stage renal disease显示文摘Carmine Zoccali Francesca Mallamaci Giovanni Tripepi 2004Journal of the American Society of Nephrology2004,15,1:1
14Cardiac consequences of hypertension in hemodialysis patients 显示文摘Zoccali C Benedetto FA Tripepi G 2004Semin Dial2004,17,:1
15Leptin in end stage renal disease:A link between fat mass,bone and the cardiovascular system显示文摘Mallamaci F Tripepi G Zoccali C 2005J Nephrol2005,18,:1
16Dissecting inflamma-tion in ESRD:do cytokines and C-reactive protein havea complementary prognostic value for mortality in dial-ysis patients?显示文摘Zoccali C Tripepi G Mallamaci F 2006J Am Soc Nephrol2006,17,123:1
17Effect of Renal Artery Stenting on Left Ventricular Mass: A Randomized Clinical Trial显示文摘Carmelita Marcantoni Luca Zanoli Stefania Rastelli Giovanni Tripepi Massimo Matalone Sarah Mangiafico Davide Capodanno Salvatore Scandura Domenico Di Landro Corrado Tamburino Carmine Zoccali Pietro Castellino 2012American Journal of Kidney Diseases2012,,1:1
18Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD : Searching for the best risk marker by multivariate mod- eling显示文摘Tripepi G Mallamaci F Zoccali C 2005J Am Soe Nephrol2005,16,31:1
19Adiponectin, Metabolic risk factors, and cardiovascular events among patients with endstage renal disease显示文摘Zoccali C Mallamaci F Tripepi G 2002J Am Soc Nephrol2002,13,1:1
20Cardiac consequences of hypertension in hemodialysis patients显示文摘Zoccali C Benedetto FA Tripepi G 2004Semin Dial2004,17,4:1
返回顶部 每页显示:
共13页 首页 上一页 第1页 下一页 末页 /13 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费